Pfizer Operating Expenses 2012-2026 | PFE

Pfizer operating expenses for the twelve months ending March 31, 2026 were $48.777B, a 3.25% decline year-over-year.

  • Pfizer annual operating expenses for 2025 were $48.335B, a 5.63% decline from 2024.
  • Pfizer annual operating expenses for 2024 were $51.216B, a 12.11% decline from 2023.
  • Pfizer annual operating expenses for 2023 were $58.274B, a 10.88% decline from 2022.

Pfizer Operating Expenses 2012-2026 | PFE

  • Pfizer annual operating expenses for 2025 were $48.335B, a 5.63% decline from 2024.
  • Pfizer annual operating expenses for 2024 were $51.216B, a 12.11% decline from 2023.
  • Pfizer annual operating expenses for 2023 were $58.274B, a 10.88% decline from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B